Mankind gets CDSCO nod for Phase 1 clinical trials for molecule to treat autoimmune disorders
The missed window: Why half of India’s people with diabetes learn too late Health experts alarmed by GST cut on beedis, demand uniform taxation AstraZeneca to invest Rs 176 cr to expand GITC in Chennai - USFDA issues Form 483 with 8 observations to Aurobindo's Telangana unit
- Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drug
- Type 2 diabetes triggering heart attacks in the 30s: Why India’s youth are at risk?
- Pharma companies cheer lower drug prices, API tax gap stirs worry
- Zydus ties up with Synthon BV for multiple sclerosis drug launch in US
- GST rate cuts complement Ayushman Bharat, PMJAY, says health ministry
- India's drug regulator eyes lighter oversight, more AI to boost efficiency
- India’s diabetes tsunami: Why it’s striking earlier and harder
- SC asks if norms in place 'actually implemented' in matter over unethical pharma practices
- GST cut on drugs, medical devices to provide relief to patients: Industry players
- Crucial drugs to be more affordable after GST cut
Biotech
- Alkem's Enzene powers into US with $70 m investment
- Govt launches advanced biomanufacturing hubs to boost bioeconomy, innovation
- PE funds vie for a majority stake in medical devices maker Sensa Core
- Civil society organisations urge govt to scrap animal testing in biosimilar development
- Abu Dhabi Investment Authority to buy 3% stake in Micro Life Sciences for $200 mn
Healthcare
- The missed window: Why half of India’s people with diabetes learn too late
- Health experts alarmed by GST cut on beedis, demand uniform taxation
- Type 2 diabetes triggering heart attacks in the 30s: Why India’s youth are at risk?
- GST rate cuts complement Ayushman Bharat, PMJAY, says health ministry
- India’s diabetes tsunami: Why it’s striking earlier and harder
Pharmaceuticals
- Mankind gets CDSCO nod for Phase 1 clinical trials for molecule to treat autoimmune disorders
- AstraZeneca to invest Rs 176 cr to expand GITC in Chennai
- USFDA issues Form 483 with 8 observations to Aurobindo's Telangana unit
- Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drug
- Pharma companies cheer lower drug prices, API tax gap stirs worry